Clinical Research Center of Reading, LLP — Wyomissing, Pennsylvania

Clinical Research Center of Reading, LLP is a clinical research site located in Wyomissing, Pennsylvania, United States 19610.

Crixeo Health Trust Score: 73/100 (FAIR). This profile has not yet been claimed by the site owner.

Clinical Research Center of Reading, LLP has participated in 9 clinical trials.

Therapeutic areas: Rheumatoid Arthritis, Fibromyalgia, Osteoarthritis, Knee.

Sponsors: Pfizer, Pfizer's Upjohn has merged with Mylan to form Viatris Inc., Eli Lilly and Company.

Sponsor Feasibility Report

Trust Score: 73/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Clinical Research Center of Reading, LLP?

Clinical Research Center of Reading, LLP has a Crixeo Trust Score of 73/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Clinical Research Center of Reading, LLP conducted?

Clinical Research Center of Reading, LLP has 9 clinical trials on record. Their work covers Rheumatoid Arthritis, Fibromyalgia, Osteoarthritis, Knee.

Is Clinical Research Center of Reading, LLP accredited by Crixeo Health?

Yes — Clinical Research Center of Reading, LLP holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about Clinical Research Center of Reading, LLP?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.